Cytokinetics Inc. buy Citigroup Inc.
Start price
07.05.25
/
50%
€29.40
Target price
07.05.26
€70.52
Performance (%)
80.27%
Price
29.12.25
€53.00
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Cytokinetics Inc. has seen massive gains of 80.27%. This prediction currently runs until 07.05.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Cytokinetics Inc. | -5.357% | -5.357% |
| iShares Core DAX® | 0.323% | 2.208% |
| iShares Nasdaq 100 | 0.145% | -0.987% |
| iShares Nikkei 225® | 0.091% | -1.421% |
| iShares S&P 500 | 0.371% | -0.469% |
Comments by Citigroup_Inc_ for this prediction
In the thread Discuss Cytokinetics Inc.
Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target lowered by analysts at Citigroup Inc. from $86.00 to $80.00. They now have a "buy" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Cytokinetics Inc.
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€41.80
02.09.25
02.09.25
€71.78
02.09.26
02.09.26
26.79%
29.12.25
29.12.25
Cytokinetics Inc.
Start price
Target price
Perf. (%)
€43.80
07.02.25
07.02.25
€82.96
07.02.26
07.02.26
21.00%
29.12.25
29.12.25